Gregory Zimet

Dr. Gregory Zimet

orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2000 in American Journal of Community Psychology
Verified
Journal Article
Closed access
PDF file
JCJanie Canty-Mitchell
Janie Canty-Mitchell
GZGregory Zimet
Gregory Zimet

1 July 1987 in Psychosomatic Medicine
Verified
Journal Article
Closed access
JBJ A Blumenthal
J A Blumenthal
MBM M Burg
M M Burg
JBJ Barefoot
J Barefoot
RWR B Williams
R B Williams
THT Haney
T Haney
GZGregory Zimet
Gregory Zimet
The interaction of Type A behavior and social support in relation to the degree of coronary artery disease (CAD) severity was investigated. One hundred thirteen patients undergoing diagnostic coronary angiography received the Type A structured interview (SI) and completed a battery of psychometric tests, including the Perceived Social Support Scale (PSSS). Statistical analyses revealed a Type by social support interaction, such that the probability of significant CAD was inversely related to the level of social support for Type As but not Type Bs. Type As with low levels of social support had more severe CAD than Type As with high levels of social support. On the other hand, this relationship was not present for Type Bs. These results are consistent with the hypothesis that social support moderates the long-term health consequences of the Type A behavior pattern.

1 January 2011 in Vaccine
Verified
Journal Article
Closed access
SRS.L. Rosenthal
S.L. Rosenthal
TWT.W. Weiss
T.W. Weiss
GZGregory Zimet
Gregory Zimet
LML. Ma
L. Ma
MGM.B. Good
M.B. Good
MVM D Vichnin
M D Vichnin

1 May 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
ADAmanda F. Dempsey
Amanda F. Dempsey
GZGregory Zimet
Gregory Zimet
RDRobert L. Davis
Robert L. Davis
LKLaura Koutsky
Laura Koutsky
OBJECTIVES. Prophylactic vaccines against human papillomavirus (HPV) are expected to be available for public use by 2007 and likely will be targeted to preadolescent children. Parental acceptance of these vaccines will be critical for their success. The objectives of this study were (1) to determine the overall acceptance of HPV vaccines for preadolescent children by parents, (2) to evaluate the influence of written educational information about HPV on parental acceptability of HPV vaccines, and (3) to identify independent predictors associated with HPV vaccine acceptability by parents. METHODS. A randomized intervention study within a cross-sectional survey was conducted. Parental HPV vaccine acceptability was measured under 3 different hypothetical scenarios. A self-administered survey on the knowledge, attitudes, and beliefs about HPV and HPV vaccines was sent to 1600 parents of 8- to 12-year-old children. In addition to a baseline paragraph about HPV that was received by all study participants, a random half of the study participants received a detailed “HPV Information Sheet” outlining the epidemiology and potential clinical sequelae of HPV infection. Independent predictors of parental HPV vaccine acceptability were determined using multivariate linear regression models. RESULTS. Parents who received the HPV information sheet had higher mean scores on the HPV knowledge assessment tool than the control group. However, despite this apparent improvement in knowledge, there was not a statistically significant difference in HPV vaccine acceptability between the 2 groups. CONCLUSIONS. Providing parents with an HPV information sheet did seem to improve knowledge about HPV, but this increased knowledge had little effect on the acceptability of these vaccines by parents for their children. Instead, attitudes and life experiences seemed to be more important factors influencing HPV vaccine acceptability among parents.

1 April 2014 in Vaccine
Verified
Journal Article
Closed access
LFLinda Y. Fu
Linda Y. Fu
LBLize-Anne Bonhomme
Lize-Anne Bonhomme
SCSpring Chenoa Cooper
Spring Chenoa Cooper
JJJill G. Joseph
Jill G. Joseph
GZGregory Zimet
Gregory Zimet

1 January 2013 in Preventive Medicine
Verified
Journal Article
Open access
JWJo Waller
Jo Waller
RORemo Ostini
Remo Ostini
LMLaura A.V. Marlow
Laura A.V. Marlow
KMKirsten McCaffery
Kirsten McCaffery
GZGregory Zimet
Gregory Zimet
Public understanding of HPV is important to ensure informed participation in cervical cancer prevention programmes. While many studies have measured HPV knowledge, none has developed a validated measure for use across countries. We aimed to develop and validate such a measure. Items tapping knowledge of HPV, HPV testing and HPV vaccination were developed from previous literature and with expert consultation. The 29-item measure was administered via the internet to 2409 adults in the UK, US and Australia in 2011. Classical test theory and item response theory were used to establish the measure's psychometric properties. Total scale reliability was very good (α = 0.838), as was internal consistency for a 16-item general HPV knowledge subset (α = 0.849). Subsets of HPV testing and vaccination items showed reasonable test-retest reliability (r(test-retest) = 0.62 and 0.69) but moderate internal consistency (α = 0.52 and 0.56). Dimensionality analyses suggested that one item was not measuring the same construct as the remainder of the questionnaire. A 2-parameter logistic item response theory (IRT) model was fitted to the remaining 28 scale items. A structurally coherent set of items covering a range of important HPV knowledge was developed. Responses indicated a reliable questionnaire, which allowed the fitting of an IRT model.